Md. Kamrul Hasan | Biomedical Engineering | Best Researcher Award

Mr. Md. Kamrul Hasan | Biomedical Engineering
| Best Researcher Award

Lecturer and Head of the Department at Teesta University, Bangladesh.

Mr. Md. Kamrul Hasan is currently serving as the Head of the Department of Electrical and Electronic Engineering (EEE) at Teesta University, Rangpur, Bangladesh. A passionate educator and researcher, he holds both B.Sc. and M.Sc. degrees in EEE from Islamic University, Kushtia. His work focuses on thermoelectric materials, renewable energy systems, and smart technologies. He has demonstrated leadership in academic project design, thesis supervision, and publication in peer-reviewed journals. His career objective emphasizes contributing to the academic field through teaching and impactful research. With expertise in thermoelectric modules, material synthesis, and smart system development, Mr. Hasan has become a promising voice in electrical engineering and applied sciences, aiming to shape the future of energy-efficient technologies.

🌍 Professional Profile:

Scopus

ORCID

Google Scholar 

🏆 Suitability for the Best Researcher Award :

Md. Kamrul Hasan’s suitability for the Best Researcher Award stems from his outstanding dedication to cutting-edge research and academic innovation. His contributions in thermoelectric generator optimization, renewable energy, material science, and smart technologies have resulted in impactful findings and scholarly publications. He has designed and implemented multiple energy-harvesting systems and led innovative projects such as Bi₂Te₂.₇Se₀.₃ thermoelectric modules and PbO nanoparticles for biomedical use. As HOD at Teesta University, he combines leadership, mentorship, and scientific advancement, cultivating research excellence in his department. His continuous efforts to integrate theoretical knowledge with experimental applications exemplify his scholarly impact, making him a strong contender for recognition as a leading researcher in electrical and electronic engineering.

🎓 Education :

Md. Kamrul Hasan pursued his entire higher education in Electrical and Electronic Engineering (EEE) at Islamic University, Kushtia, Bangladesh. He completed his M.Sc. in Engineering in 2021 with a CGPA of 3.75 (Thesis Group), conducting advanced research in energy harvesting via thermoelectric modules. Prior to this, he earned his B.Sc. in Engineering in 2020, with a CGPA of 3.60, where he focused on embedded systems with a radar-based object detection project. His academic foundation began with strong results in pre-university education: he passed HSC in 2015 from Shathibari College with a GPA of 4.75 and SSC in 2013 from Sathibari M.L. High School, securing a perfect GPA of 5.00. His consistent academic excellence reflects his deep-rooted passion for engineering and innovation.

🏢 Work Experience :

Currently the Head of the EEE Department at Teesta University, Rangpur, Md. Kamrul Hasan brings academic leadership and technical expertise to his role. With a strong focus on research-led teaching, he mentors students in project development and thesis execution. His M.Sc. thesis involved optimizing thermoelectric modules, while his B.Sc. project introduced an Arduino-based radar system. Beyond academics, he has led experiments in designing PbTe-based thermoelectric coolers, synthesizing Bi₂Te₂.₇Se₀.₃ and PbO nanoparticles, and developing energy-efficient systems. His hands-on experience with material characterization, sensor design, and automation technologies underpins his practical teaching methods. As a departmental head, he fosters a collaborative research culture and contributes significantly to curriculum enhancement, institutional development, and academic excellence.

🏅Awards and Honors

While formal award recognitions are still growing in his academic journey, Md. Kamrul Hasan has achieved noteworthy distinctions through his impactful research and leadership. His appointment as Head of the EEE Department at a young stage in his career signifies institutional trust in his scholarly capabilities. He has published in international journals, including a 2024 paper on optimizing Bi₂Te₃ thermoelectric coolers with numerical simulations, marking his contribution to renewable energy and material science. He has also been invited for collaborative research with international academics, demonstrating recognition beyond his institution. His innovative undergraduate and postgraduate projects have received acclaim from academic panels, positioning him as a rising researcher with the potential to earn national and international accolades in the near future.

🔬 Research Focus :

Md. Kamrul Hasan’s research revolves around sustainable technologies and smart energy systems. His core focus includes thermoelectric generators and coolers, renewable energy harvesting, semiconductor materials, thin films, and solar cells. He has also explored biomedical engineering applications, such as PbO nanoparticles for anticancer research. His work integrates simulation-based design and experimental validation to optimize thermoelectric performance and develop next-generation energy devices. He is particularly interested in Bi₂Te₂.₇Se₀.₃ and PbTe-based thermoelectric materials and has successfully designed and characterized custom modules for waste heat recovery. His interdisciplinary interests extend to embedded systems, information and communication technologies, and sensor-based robotics, demonstrating his versatility in addressing both energy and automation challenges. He aims to bridge the gap between theoretical science and practical solutions.

📊 Publication Top Notes:

📘 Optimizing the performance of Bi₂Te₃ TECs through numerical simulations using COMSOL Multiphysics2024, Cited by: 4
📗 Enhancing PV performance of Al/ZnO/CdS/GaAs/NiO/Au solar cells through diverse layer combinations by SCAPS-1D2025, Cited by: 1
📙 Enhancing Bi₂Te₂.₇₀Se₀.₃₀ Thermoelectric Module Performance through COMSOL Simulations2024, Cited by: 1
📘 Optimizing layer configuration and material selection to enhance CIGS solar cell performance through computational simulation2025.
📗 Optimizing FASnI₃ perovskite solar cells: Advancements with organic and inorganic transport layers2025. 
📙 Enhancing the performance of FAPbI₃ using organic and inorganic transport layers in perovskite solar cells2025. 
📘 Influence of Leg Geometry on the Performance of Bi₂Te₃ Thermoelectric Generators2024 . 

Fang Li | Gynecology | Excellence in Innovation Award

Prof. Fang Li | Gynecology| Excellence in Innovation Award

Prof. Fang Li ,Oriental Hospital Affiliated to Tongji University, China

Dr. Fang Li is a distinguished gynecologic oncologist, academic leader, and professor at Tongji University’s Shanghai East Hospital. With over 20 years of clinical experience, he specializes in diagnosing and treating cervical precancerous lesions and gynecologic tumors, utilizing laparoscopic, robotic, and open surgeries. A graduate of Tongji Medical College, he has conducted groundbreaking research on high-risk HPV and its role in cervical cancer. His innovative contributions include establishing an HPV16 evolutionary tree and developing an in vivo microendoscopic pathological diagnosis system. As a visiting scholar at the University of Cambridge, he advanced research in gynecologic oncology. His work, widely published in high-impact journals, has significantly influenced precision treatment and immunotherapy strategies for cervical cancer.

🌍 Professional Profile:

Scopus

🏆 Suitability for the Excellence in Innovation Award

Dr. Fang Li’s pioneering research in gynecologic oncology makes him an ideal candidate for the Excellence in Innovation Award. His discoveries on high-risk HPV integration and single-cell tumor microenvironment analysis have revolutionized cervical cancer diagnostics and treatment. His innovative development of a microendoscopic in vivo pathological diagnosis system enhances real-time cervical cancer detection, advancing precision medicine. His translational research has led to novel immunotherapy strategies, improving patient outcomes. A leader in clinical application and academic research, he has published extensively in high-impact journals, influencing global gynecologic oncology practices. His work exemplifies groundbreaking innovation with direct clinical impact, improving women’s health worldwide through early detection and targeted therapy advancements.

🎓 Education 

Dr. Fang Li earned his M.D. and Ph.D. in Obstetrics and Gynecology from Tongji Medical College of Huazhong University of Science and Technology under the mentorship of Academician Ma Ding. With a strong foundation in gynecologic oncology, he has pursued specialized training and research in high-risk HPV and cervical cancer pathogenesis. As a China Scholarship Council-sponsored visiting scholar, he conducted advanced research at the University of Cambridge’s Department of Genetics and the Gynecologic Oncology and Endoscopy Center at Addenbrooke’s Hospital. His academic training, enriched by global exposure and cutting-edge research, has shaped his expertise in precision oncology, immunotherapy, and minimally invasive surgical techniques, making him a leader in gynecologic cancer research and treatment.

🏢 Work Experience 

Since 2005, Dr. Fang Li has been actively engaged in clinical, teaching, and research work at the Affiliated Hospital of Tongji University. In 2019, he joined Shanghai East Hospital, where he serves as the Director of Gynecological Oncology. His expertise spans over 20 years, specializing in cervical precancerous lesions, cervical cancer, and gynecologic tumor management. He is proficient in advanced surgical techniques, including laparoscopic, robotic, and single-port procedures. His experience also includes international research collaborations at the University of Cambridge, where he investigated HPV-related carcinogenesis. With a patient-first approach, he has treated nearly 200,000 gynecological patients, earning their trust and recognition. His leadership in oncology research and clinical innovation continues to shape modern gynecologic cancer treatment.

🏅 Awards and Honors 

Dr. Fang Li has received numerous accolades for his contributions to gynecologic oncology. His research on high-risk HPV integration and cervical cancer microenvironment analysis has earned recognition in top-tier scientific journals. He has received multiple research grants and academic awards, including funding from the China Scholarship Council for international collaboration. His groundbreaking work on microendoscopic in vivo diagnosis won prestigious innovation awards in medical technology. His contributions to immunotherapy strategies have been acknowledged at international oncology conferences. As a respected leader in gynecologic oncology, he continues to receive honors for his advancements in precision medicine and minimally invasive surgical techniques. His accolades reflect his dedication to improving cancer diagnostics and treatment through innovative research and clinical excellence.

🔬 Research Focus 

Dr. Fang Li’s research primarily focuses on gynecologic oncology, with an emphasis on high-risk HPV and cervical cancer pathogenesis. His groundbreaking studies on HPV16 integration sites and fusion transcripts have identified critical carcinogenic factors. His pioneering work in single-cell transcriptomics has revealed key immune microenvironment subpopulations, advancing immunotherapy strategies. He has also developed a microendoscopic in vivo pathological diagnosis system for real-time cervical cancer detection. His research extends to targeted therapies, precision oncology, and the role of transcription factors in tumor progression. By integrating genomics, immunotherapy, and surgical innovations, Dr. Li’s work contributes to improving early cancer detection, patient survival rates, and the development of novel treatment protocols for gynecologic malignancies.

📊 Publication Top Notes:

  • Ren, X., Zhou, W., Yuan, N., Ruan, Y., & Zhou, H. (2025). Prompt-based polyp segmentation during endoscopy. Medical Image Analysis.

  • Niu, S., Kong, D. X., Li, C., Li, F., & Lei, L. (Year not provided). Influence of Hormonal Contraceptive Usage on Risk of Endometriosis.

  • Yeshe, P., & Li, F. (2024). Clinical efficacy and safety of neoadjuvant chemotherapy with paclitaxel and cisplatin in combination with concurrent chemoradiotherapy for locally advanced cervical cancer: a systematic review and meta-analysis. Journal of Radiation Research.

  • Xiao, Y., Zhi, Y., Cao, G., Gao, J., & Li, F. (2024). Primary Ewing’s sarcoma of the uterine cervix: a case report and review of the literature. Journal of Cancer Research and Clinical Oncology.

  • Hu, B., Wang, R., Wu, D., Sun, C., & Liao, S. (2024). A Promising New Model: Establishment of Patient-Derived Organoid Models Covering HPV-Related Cervical Pre-Cancerous Lesions and Their Cancers. Advanced Science.

  • Liu, M., Lu, J., Zhi, Y., Gao, J., & Li, F. (2023). Microendoscopy in vivo for the pathological diagnosis of cervical precancerous lesions and early cervical cancer. Infectious Agents and Cancer.

Zinuo Yuan | Endocrinology | Best Researcher Award

Zinuo Yuan | Endocrinology | Best Researcher Award

Shandong University, China

👨‍🎓Profiles

🎓 Early Academic Pursuits

Zinuo Yuan began her academic journey with a Bachelor’s degree in Clinical Medicine, which she followed with a Master’s degree from Shandong University. This foundation in clinical medicine provided her with the necessary expertise to delve into complex health issues and propelled her toward research in endocrinology and cancer.

👩‍⚕️ Professional Endeavors

Yuan currently serves as a Medical Doctor (MD) in the Department of Endocrinology at Shandong Provincial Hospital, affiliated with Shandong University. Her role there allows her to integrate clinical insights into her research, examining the links between metabolic health and cancer. She has developed a strong focus on the clinical and biochemical mechanisms of metabolic abnormalities, aiming to improve outcomes in patients with obesity-related cancers.

🔍 Research Focus and Innovation

Her primary research revolves around the impact of obesity and metabolic disorders on cancer, particularly looking at how lipo-toxic interventions may offer protective benefits. This innovative approach is helping to uncover potential therapeutic strategies that could significantly influence cancer treatment. To date, she has published nine articles, enriching academic discourse on these topics and opening new avenues for research.

🌍 Impact and Influence

Yuan’s work in exploring lipo-toxic interventions has made an impact on both academic and clinical communities. Her findings have contributed to preventative strategies in oncology, offering insights that could reshape treatment approaches for cancer patients affected by metabolic issues. Her research has spurred further studies, proving to be valuable in both scholarly and practical applications.

📈 Academic Publications and Citations

Yuan has contributed nine publications to journals indexed in SCI and Scopus, which underscores her engagement with evidence-based research in clinical medicine. While her research has garnered interest, she has no editorial appointments or patents. Her citation index can be accessed via Clarivate’s Web of Science, showcasing her academic impact.

💻 Technical Skills

Through her research, Yuan has developed specialized skills in endocrinology and cancer metabolism. She brings analytical prowess to clinical studies, making her adept at bridging the gap between clinical observations and laboratory findings. Her proficiency extends to interpreting complex biochemical and physiological data, which is instrumental in her research.

📚 Teaching and Mentorship Experience

Though no specific teaching experience is highlighted, Yuan’s publications and her active involvement in clinical research are valuable for students and colleagues alike. By sharing her findings and methodologies through published work, she indirectly mentors emerging scholars in her field.

🔮 Legacy and Future Contributions

Yuan’s work in endocrinology and cancer prevention shows promise for ongoing contributions to medical science. Her research on obesity and its links to cancer may lead to groundbreaking treatments, potentially positioning her as a leader in developing innovative cancer therapies. Her dedication suggests a commitment to further research and impactful medical practices that could shape future cancer treatment protocols.

📖Notable Publications

Longitudinal cohort study highlights cancer-preventive benefits of lipid-lowering drugs

Authors: Yuan, Z., Ding, C., Duan, J., ... Zhao, J., Fan, X.
Journal: iScience
Year: 2024

Obesity Metabolic Phenotypes and Unplanned Readmission Risk in Diabetic Kidney Disease: An Observational Study from the Nationwide Readmission Database

Authors: Zhang, W., Du, J., Dong, H., ... Han, W., Fan, X.
Journal: Archives of Medical Research
Year: 2023

Association of obesity under different metabolic status with adverse outcomes in patients with chronic myeloid leukemia: A retrospective cohort study

Authors: Dong, Y., Cheng, Y., Feng, X., ... Fan, X., Zhao, J.
Journal: Journal of Diabetes
Year: 2023

Association between Metabolic Obesity Phenotypes and the Burden of Hospitalized Postmenopausal Patients Concomitant with Osteoporosis: A Retrospective Cohort Study Based on the National Readmission Database

Authors: Jiang, J., Xu, C., Yuan, Z., ... Fan, X., Zhao, J.
Journal: Journal of Clinical Medicine
Year: 2023

Changes in Clinical Manifestations Due to AFLD Retyping Based on the New MAFLD Criteria: An Observational Study Based on the National Inpatient Sample Database

Authors: Feng, X., Xuan, R., Dong, Y., ... Zhao, J., Fan, X.
Journal: Diagnostics
Year: 2023

The impact of metabolic overweight/obesity phenotypes on unplanned readmission risk in patients with COPD: a retrospective cohort study

Authors: Tian, Y., Liu, L., Li, Y., ... Xuan, Q., Xu, C.
Journal: Frontiers in Physiology
Year: 2023

Association between metabolic obesity phenotypes and multiple myeloma hospitalization burden: A national retrospective study

Authors: Zhang, Y., Fan, X., Zhao, C., ... Zhao, Y., Lu, K.
Journal: Frontiers in Oncology
Year: 2023